TL;DR
This study investigates whether recent antibiotic use increases the risk of hospitalization for acute gastroenteritis (AGE) in Korean children. It finds that antibiotic exposure is indeed a significant risk factor, but importantly, this risk can be mitigated by prescribing probiotics concurrently.
What Problem Does This Paper Address?
Acute gastroenteritis (AGE) is a common childhood illness that can lead to significant healthcare burdens, including hospitalizations. While often self-limiting and viral in origin, disruptions to the gut microbiota, particularly from antibiotic use, are suspected to exacerbate AGE and its complications. However, robust, large-scale evidence directly linking recent antibiotic exposure to increased AGE hospitalization risk in children, and exploring potential protective measures like probiotics, has been limited. This paper aims to fill that gap by examining this association in a nationwide cohort.
Methods
The researchers employed a retrospective cohort study design, leveraging data from the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC). This dataset contains comprehensive health insurance claims for a representative sample of the Korean population.
Key methodological aspects include:
- Target Population: Children aged up to 18 years diagnosed with presumed non-bacterial AGE.
- Exposure Definition: Recent antibiotic exposure was defined as antibiotic therapy within 14 days prior to the index AGE visit. The duration of exposure was categorized into no exposure, 1-3 days, 4-7 days, and >7 days.
- Outcome Measure: The primary outcome was hospitalization within 7 days of the index AGE visit. Secondary outcomes included ICU admission and death during hospitalization.
- Covariate: Prescription of probiotics at the time of the index visit was considered a key covariate.
- Statistical Analysis: Chi-squared tests and Fisher's exact tests were used for group comparisons. Logistic regression models were employed to assess associations, including multivariable models with interaction terms to evaluate the modifying effect of probiotics on antibiotic exposure.
Datasets
The study utilized the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC). This is a large, nationwide, population-based dataset comprising claims data from approximately one million individuals, representing 2% of the Korean population. It includes diagnostic codes (ICD-10), prescription codes (ATC), procedure codes, costs, and patient demographics. The data used spanned from 2002 to 2013.
Key Insights and Ideas
- Antibiotics as a Gut Disruptor: The study reinforces the understanding that antibiotics, while crucial for treating bacterial infections, can disrupt the delicate balance of the gut microbiota. This disruption appears to make children more susceptible to complications from AGE, leading to increased hospitalization.
- Probiotics as a Protective Modulator: The most compelling insight is the potential of probiotics to mitigate the increased hospitalization risk associated with prior antibiotic exposure. This suggests a targeted therapeutic strategy for children at risk.
- Duration Matters: The risk of hospitalization appears to be dose-dependent, increasing with longer durations of antibiotic exposure. This highlights the importance of judicious antibiotic prescribing.
- AGE Severity and Age Susceptibility: The study notes that younger children (<6 years) may be more susceptible to dehydration from AGE, leading to higher hospitalization rates, even for milder cases.
Key Results
- Out of 275,395 identified AGE cases, 18.5% had prior antibiotic exposure.
- Hospitalization within 7 days of the index visit was significantly positively associated with prior antibiotic exposure (p-trend < 0.001).
- Prescription of probiotics was associated with a decreased risk of hospitalization (OR 0.80; 95% CI 0.72–0.87).
- The interaction between antibiotic exposure and probiotic prescription was statistically significant for prolonged antibiotic use (>7 days), indicating that probiotics were particularly beneficial in this subgroup (OR 0.53; 95% CI 0.43–0.83; p = 0.002).
- Specifically, for antibiotic exposure >7 days, the odds ratio for hospitalization was 2.43 without probiotics but dropped to 1.29 when probiotics were prescribed.
Limitations and Future Work
The authors acknowledge several limitations:
- Data Age: The data is from over seven years ago, and current clinical practices might have evolved. However, they argue the fundamental impact of antibiotics on gut microbiota remains relevant.
- Lack of Severity/Lab Data: The NHIS-NSC dataset does not include detailed disease severity markers or laboratory data, preventing a precise assessment of treatment appropriateness. Hospitalization was used as a proxy for severity.
- Exclusion of Bacterial AGE: The study focused on non-bacterial AGE, excluding bacterial cases, thus limiting conclusions about bacterial AGE and probiotic interactions.
- Antibiotic/Probiotic Specificity: The dataset did not specify the types of antibiotics or probiotics used, preventing an analysis of which specific agents are most harmful or protective.
- Causality: As a cohort study, it establishes association but cannot definitively prove causality between antibiotics and hospitalization.
- Unmeasured Confounders: Despite adjustments, unmeasured factors like body mass index, diet, and family history could still influence the results.
Future work could involve individualized studies on bacterial AGE, research into specific antibiotic and probiotic agents, and prospective studies to confirm causality.
Summary updated